PLTP activity decreases with weight loss: Changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity

Journal of Lipid Research

Volumn 44, Issue 9, 2003, Pages 1705-1712

  Murdoch, Susan J ^a   Kahn, Steven E ^a,b   Albers, John J ^a   Brunzell, John D ^a   Purnell, Jonathan Q ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Puget Sound Veterans Administration Health Care System   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Diabetes; Free fatty acid; Intraabdominal fat; Leptin; Obesity; Phospholipid transfer protein

Indexed keywords

FATTY ACID; LEPTIN; LIPID; PHOSPHOLIPID TRANSFER PROTEIN;

ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ABDOMEN; ADIPOSE TISSUE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MEMBRANE PROTEINS; OBESITY; PHOSPHOLIPID TRANSFER PROTEINS; SUBCUTANEOUS TISSUE; WEIGHT LOSS;

EID: 0141682469     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300073-JLR200     Document Type: Article

References (42)

1. van Tol, A. 2002. Phospholipid transfer protein. Curr. Opin. Lipidol. 13: 135-139.
2. Murdoch, S. J., and W. C. Breckenridge. 1996. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Biochim. Biophys. Acta. 1303: 222-232.
3. Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta. 1439: 65-76.
4. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
5. Tall, A. R., S. Krumholz, T. Olivecrona, and R. J. Deckelbaum. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J. Lipid Res. 26: 842-851.
6. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602.
7. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
8. Murdoch, S. J., M. C. Carr, J. E. Hokanson, J. D. Brunzell, and J. J. Albers. 2000. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J. Lipid Res. 41: 237-244.
9. Jiang, X. C., S. Qin, C. Qiao, K. Kawano, M. Lin, A. Skold, X. Xiao, and A. R. Tall. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7: 847-852.
10. Murdoch, S. J., M. C. Carr, H. Kennedy, J. D. Brunzell, and J. J. Albers. 2002. Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J. Lipid Res. 43: 1256-1263.
11. Cheung, M. C., R. H. Knopp, B. Retzlaff, H. Kennedy, G. Wolfbauer, and J. J. Albers. 2002. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. Biochim. Biophys. Acta. 1587: 53-59.
12. Dullaart, R. P., W. J. Sluiter, L. D. Dikkeschei, K. Hoogenberg, and A. Van Tol. 1994. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24: 188-194.
13. Kaser, S., A. Sandhofer, B. Foger, C. F. Ebenbichler, B. Igelseder, L. Malaimare, B. Paulweber, and J. R. Patsch. 2001. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia. 44: 1111-1117.
14. Riemens, S. C., A. van Tol, W. J. Sluiter, and R. P. Dullaart. 1998. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia. 41: 929-934.
15. Desrumaux, C., A. Athias, G. Bessede, B. Verges, M. Farnier, L. Persegol, P. Gambert, and L. Lagrost. 1999. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subject as measured by a specific ELISA. Arterioscler. Thromb. Vasc. Biol. 19: 266-275.
16. Colhoun, H. M., L. M. Scheek, M. B. Rubens, T. Van Gent, S. R. Underwood, J. H. Fuller, and A. Van Tol. 2001. Lipid transfer protein activities in type I diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes. 50: 652-659.
17. Van Tol, A., J. J. Ligtenberg, S. C. Riemens, T. W. van Haeften, W. D. Reitsma, and R. P. Dullaart. 1997. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand. J. Clin. Lab. Invest. 57: 147-157.
18. Riemens, S. C., A. Van Tol, B. K. Stulp, and R. P. Dullaart. 1999. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J. Lipid Res. 40: 1467-1474.
19. Cnop, M., M. J. Landchild, J. Vidal, P. J. Havel, N. G. Knowles, D. R. Carr, F. Wang, R. L. Hull, E. J. Boyko, B. M. Retzlaff, C. E. Walden, R. H. Knopp, and S. E. Kahn. 2002. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 51: 1005-1015.
20. Dusserre, E., P. Moulin, and H. Vidal. 2000. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim. Biophys. Acta. 1500: 88-96.
21. Warnick, G. R. 1986. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 129: 101-123.
22. Cheung, M. C., G. Wolfbauer, and J. J. Albers. 1996. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim. Biophys. Acta. 1303: 103-110.
23. Iverius, P. H., and J. D. Brunzell. 1985. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am. J. Physiol. 249: E107-E114.
24. Beard, J. C., R. N. Bergman, W. K. Ward, and D. Porte, Jr. 1986. The insulin sensitivity index in nondiabetic matt. Correlation between champ-derived and IVGTT-derived values. Diabetes 35: 362-369.
25. Morgan, C. R. 1963. Immunoassay of insulin: two antibody systems. Diabetes. 35: 362-369.
26. Bergman, R. N., Y. Z. Ider, C. R. Bowden, and C. Cobelli. 1979. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236: E667-E677.
27. Bergman, R. N., R. Prager, A. Volund, and J. M. Olefsky. 1987. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79: 790-800.
28. Ma, Z., R. L. Gingerich, J. V. Santiago, S. Klein, C. H. Smith, and M. Landt. 1996. Radioimmunoassay of leptin in human plasma. Clin. Chem. 42: 942-946.
29. Shuman, W. P., L. L. Morris, D. L. Leonetti, P. W. Wahl, V. M. Moceri, A. A. Moss, and W. Y. Fujimoto. 1986. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest. Radiol. 21: 483-487.
30. Borkan, G. A., S. G. Gerzof, A. H. Robbins, D. E. Hults, C. K. Silbert, and J. E. Silbert. 1982. Assessment of abdominal fat content by computed tomography. Am. J. Clin. Nutr. 36: 172-177.
31. Tokunda, Y. M., K. Ishikawa, and S. Tarui. 1983. A novel technique for the determination of body fat by computed tomography. Int. J. Obes. 7: 437-445.
32. Kaser, S., B. Foger, C. F. Ebenbichler, R. Kirchmair, R. Gander, A. Ritsch, A. Sandhofer, and J. R. Patsch. 2001. Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int. J. Obes. Relat. Metab. Disord. 25: 1633-1639.
33. Liinamaa, M. J., M. L. Hannuksela, Y. A. Kesaniemi, and M. J. Savolainen. 1997. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler. Thromb. Vasc. Biol. 17: 2940-2947.
34. Lagrost, L., A. Athias, B. Herbeth, V. Guyard-Dangremont, Y. Artur, F. Paille, P. Gambert, and C. Lallemant. 1996. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J. Biol. Chem. 271: 19058-19065.
35. Riemens, S. C., A. van Tol, W. J. Sluiter, and R. P. Dullaart. 1999. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes. 48: 1631-1637.
36. Hiln, A. K., L. Michalik, and W. Wahli. 2002. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59: 790-798.
37. Bouly, M., D. Masson, B. Gross, X. C. Jiang, C. Fievet, G. Castro, A. R. Tall, J. C. Fruchart, B. Staels, L. Lagrost, and G. Luc. 2001. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J. Biol. Chem. 276: 25841-25847.
38. Tu, A. Y., and J. J. Albers. 1999. DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem. Biophys. Res. Commun. 264: 802-807.
39. Urizar, N. L., D. H. Dowhan, and D. D. Moore. 2000. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275: 39313-39317.
40. Albers, J. J., G. Wolfbauer, M. C. Cheung, J. R. Day, A. F. Ching, S. Lok, and A. Y. Tu. 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
41. Murdoch, S. J., G. Wolfbauer, H. Kennedy, S. M. Marcovina, M. C. Carr, and J. J. Albers. 2002. Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. J. Lipid Res. 43: 281-289.
42. Oka, T., T. Kujiraoka, M. Ito, T. Egashira, S. Takahashi, M. N. Nanjee, N. E. Miller, J. Metso, V. M. Olkkonen, C. Ehnholm, M. Jauhiainen, and H. Hattori. 2000. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J. Lipid Res. 41: 1651-1657.